Here are four things to know:
1. The proposal would cut production quotas for oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl by 7-15 percent, in 2019, according to
2. The proposed drug manufacturing cut coincides with President Donald Trump’s “Safe Prescribing Plan,” which seeks to reduce opioid prescription fills by one-third over the next three years.
3. This past March, President Trump also revealed a tougher antiopioid campaign to cut opioid prescriptions by adjusting federal programs to cut opioid prescriptions and boost funding. He also proposed the death penalty for dealers.
4. The DEA and Justice Department’s proposal comes on the heels of a CDC estimate, showing 48,612 Americans died from opioid overdoses in 2017.
More articles on opioids:
72K Americans died from drug overdoses in 2017, CDC estimates
80+ people overdose in a Connecticut park in 1 day
Physician- & organization-related initiatives effective at lowering opioid prescriptions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.